Literature DB >> 12652297

Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2.

Anje Cauwels1, Ben Janssen, Anouk Waeytens, Claude Cuvelier, Peter Brouckaert.   

Abstract

Dysregulated apoptotic cell death contributes to many pathological conditions, including sepsis, prompting the suggestion that caspase inhibition to block apoptosis could have useful therapeutic applications. Because the cytokine tumor necrosis factor (TNF, also known as TNF-alpha) is both pro-apoptotic and pro-inflammatory and is involved in septic shock, we tested whether caspase inhibition would alleviate TNF-induced toxicity in vivo. General caspase inhibition by the protease inhibitor zVAD-fmk exacerbated TNF toxicity by enhancing oxidative stress and mitochondrial damage, resulting in hyperacute hemodynamic collapse, kidney failure and death. Thus, survival of TNF toxicity depends on caspase-dependent processes. Our results demonstrated the pathophysiological relevance of caspase-independent, ROS-mediated pathways in response to lethal TNF-induced shock in mice. In addition, survival of TNF toxicity seemed to require a caspase-dependent protective feedback on excessive reactive oxygen species (ROS) formation and phospholipase A2 activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652297     DOI: 10.1038/ni914

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  63 in total

Review 1.  The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

Authors:  B McLaughlin
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

Review 2.  Non-caspase proteases: triggers or amplifiers of apoptosis?

Authors:  Karen Schrader; Jisen Huai; Lars Jöckel; Carolin Oberle; Christoph Borner
Journal:  Cell Mol Life Sci       Date:  2010-02-19       Impact factor: 9.261

Review 3.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  When apoptosis meets autophagy: deciding cell fate after trauma and sepsis.

Authors:  Ya-Ching Hsieh; Mohammad Athar; Irshad H Chaudry
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 5.  Caspase-independent cell death: leaving the set without the final cut.

Authors:  S W G Tait; D R Green
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 6.  Advances in understanding sepsis.

Authors:  M Shimaoka; E J Park
Journal:  Eur J Anaesthesiol Suppl       Date:  2008

7.  Infliximab in ulcerative colitis.

Authors:  Avi Levin; Oren Shibolet
Journal:  Biologics       Date:  2008-09

8.  Differential protection by wildtype vs. organelle-specific Bcl-2 suggests a combined requirement of both the ER and mitochondria in ceramide-mediated caspase-independent programmed cell death.

Authors:  Andrea Deerberg; Justyna Sosna; Lutz Thon; Claus Belka; Dieter Adam
Journal:  Radiat Oncol       Date:  2009-10-09       Impact factor: 3.481

9.  Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections.

Authors:  Janie Parrino; Richard S Hotchkiss; Mike Bray
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner.

Authors:  Anje Cauwels; Emmanuel S Buys; Robrecht Thoonen; Lisa Geary; Joris Delanghe; Sruti Shiva; Peter Brouckaert
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.